Clinical Trials in New York

Showing 8881-8900 of 22,668 trials

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

NCT05705505

This study will assess the safety and efficacy of increasing doses of narazaciclib (ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer and other Gynecologic Malignancies.

Endometrioid Endometrial Cancer

Traws Pharma, Inc.60 participantsStarted Mar 2023

Tucson, Arizona, United States • Minneapolis, Minnesota, United States • Mineola, New York, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

NCT03905330

The purpose of this study is to determine whether the investigational treatment (maralixibat) is safe and effective in pediatric participants with Progressive Familial Intrahepatic Cholestasis (PFIC).

Progressive Familial Intrahepatic Cholestasis (PFIC)

Mirum Pharmaceuticals, Inc.93 participantsStarted Jul 2019

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Orlando, Florida, United States +28 more locations

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

Find Trials by Condition in New York

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

A Study of PRT2527 in Participants With Advanced Solid Tumors

Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

Efficacy and Safety of BIIB111 for the Treatment of Choroideremia

Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy

Straberi Epistamp Device for Postinflammatory Hyperpigmentation

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

Unwinding Anxiety for Migraine: Pilot

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

Approaches and Decisions for Acute Pediatric TBI Trial

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

Examine the Psychosocial Impacts of COVID-19 Pandemic.